Khade Shalaka, Nalwa Aasma, Rao Meenakshi, Aggarwal Divya, Sharma Vidhu, Chugh Ankita
Department of Pathology, All India Institute of Medical Sciences, Rajasthan, India.
Oman Med J. 2023 May 31;38(3):e511. doi: 10.5001/omj.2023.16. eCollection 2023 May.
COVID-19 is a relatively new disease whose complete pathogenesis and complications have not been elucidated. Apart from the morbidity and mortality caused by the virus itself, it is noted that patients affected with this virus have a higher susceptibility to bacterial and fungal co-infections. Mucormycosis is a rare and life-threatening fungal infection generally associated with uncontrolled diabetes mellitus and immunosuppression. It tends to rapid disease progression and poor prognosis if not diagnosed and managed promptly. There has been a sudden increase in the number of mucormycosis cases in patients with moderate to severe COVID-19 infection in the past few months. Herein, we present a series of 10 mucormycosis cases diagnosed over one week.
新型冠状病毒肺炎（COVID-19）是一种相对较新的疾病，其完整的发病机制和并发症尚未阐明。除了病毒本身引起的发病率和死亡率外，值得注意的是，感染这种病毒的患者更容易发生细菌和真菌合并感染。毛霉病是一种罕见且危及生命的真菌感染，通常与未控制的糖尿病和免疫抑制有关。如果不及时诊断和治疗，它往往会导致疾病迅速进展且预后不良。在过去几个月中，中度至重度COVID-19感染患者中毛霉病病例数突然增加。在此，我们报告了在一周内确诊的10例毛霉病病例。
